•
Sep 30, 2019

Boston Scientific Q3 2019 Earnings Report

Total Revenue
$2.71B
Previous year: $2.39B
+13.1%
EPS
$0.39
Previous year: $0.35
+11.4%
Gross Profit
$1.92B
Previous year: $1.7B
+12.4%
Cash and Equivalents
$277M
Previous year: $168M
+64.9%
Free Cash Flow
$381M
Previous year: $425M
-10.4%
Total Assets
$26.8B
Previous year: $20.4B
+31.3%

Boston Scientific

Boston Scientific